In this educational activity, experts will provide information on uveitic macular edema that encompasses the epidemiology, pathophysiology, impact on vision loss, diagnostic criteria, relevant injection techniques, and efficacy and safety of current and emerging treatments.

This educational activity will help optometrists diagnose age-related macular degeneration, appropriately stage the disease, and understand the role of nutritional supplementation plus other measures that support optimal patient care.

This educational activity will improve clinicians’ familiarity with newly approved and emerging classes (Janus kinase inhibitors, sphingosine-1-phosphate receptor modulators) for the treatment of ulcerative colitis.

This educational activity is based on the proceedings of a symposium held in conjunction with the 2021 Annual Meeting of the American Urological Association on OAB that reviewed updates in the treatment of OAB, including clinical data on new and emerging treatments, and which highlighted some of the evidence on the increased risk of dementia associated with antimuscarinic use.